Junling Wang

1.3k total citations
102 papers, 980 citations indexed

About

Junling Wang is a scholar working on Economics and Econometrics, Geriatrics and Gerontology and Family Practice. According to data from OpenAlex, Junling Wang has authored 102 papers receiving a total of 980 indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Economics and Econometrics, 42 papers in Geriatrics and Gerontology and 31 papers in Family Practice. Recurrent topics in Junling Wang's work include Pharmaceutical Practices and Patient Outcomes (42 papers), Medication Adherence and Compliance (31 papers) and Health Systems, Economic Evaluations, Quality of Life (28 papers). Junling Wang is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (42 papers), Medication Adherence and Compliance (31 papers) and Health Systems, Economic Evaluations, Quality of Life (28 papers). Junling Wang collaborates with scholars based in United States, China and Japan. Junling Wang's co-authors include C. Daniel Mullins, Song Hee Hong, Fadia T. Shaya, Ilene H. Zuckerman, Nancy A. Miller, Lawrence M. Brown, Christina A. Spivey, Ya‐Chen Tina Shih, Samuel Dagogo‐Jack and Shelley I. White‐Means and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of the American Geriatrics Society.

In The Last Decade

Junling Wang

96 papers receiving 919 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junling Wang United States 16 285 262 212 156 134 102 980
Yelena Rozenfeld United States 11 147 0.5× 86 0.3× 213 1.0× 136 0.9× 151 1.1× 17 821
Roland Rapold Switzerland 13 221 0.8× 201 0.8× 138 0.7× 142 0.9× 158 1.2× 23 639
Adrian R. Levy Canada 14 126 0.4× 158 0.6× 198 0.9× 278 1.8× 107 0.8× 19 1.1k
Piotr Merks Poland 15 254 0.9× 134 0.5× 115 0.5× 92 0.6× 140 1.0× 93 790
Johanna Jyrkkä Finland 15 827 2.9× 477 1.8× 215 1.0× 157 1.0× 176 1.3× 36 1.5k
Ellen S. Koster Netherlands 24 478 1.7× 111 0.4× 364 1.7× 97 0.6× 492 3.7× 99 1.8k
Mary Teeling Ireland 13 396 1.4× 256 1.0× 154 0.7× 103 0.7× 83 0.6× 27 760
Jeffrey J. Ellis United States 13 131 0.5× 233 0.9× 152 0.7× 89 0.6× 112 0.8× 28 835
Antonio Gimeno‐Miguel Spain 17 126 0.4× 111 0.4× 87 0.4× 306 2.0× 78 0.6× 51 786
Sachin Kamal‐Bahl United States 20 111 0.4× 353 1.3× 87 0.4× 145 0.9× 229 1.7× 50 1.3k

Countries citing papers authored by Junling Wang

Since Specialization
Citations

This map shows the geographic impact of Junling Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junling Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junling Wang more than expected).

Fields of papers citing papers by Junling Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junling Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junling Wang. The network helps show where Junling Wang may publish in the future.

Co-authorship network of co-authors of Junling Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Junling Wang. A scholar is included among the top collaborators of Junling Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junling Wang. Junling Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Junling, Xiang Ma, Fei He, et al.. (2025). Prevalence of CYP2C19 Variants in Patients with Cardiovascular Disease from the Yunnan-Guizhou Plateau in Southwestern China. Pharmacogenomics and Personalized Medicine. Volume 18. 105–113. 1 indexed citations
2.
Zhang, Xiangjun & Junling Wang. (2024). The effects of medication therapy management on medication utilization among Medicare beneficiaries with HIV/AIDS. Journal of the American Pharmacists Association. 64(2). 463–470.e2.
3.
Wang, Junling, et al.. (2023). Effects of star ratings bonus payments on disparities in medication utilization issues. SHILAP Revista de lepidopterología. 11. 100323–100323. 2 indexed citations
4.
Wan, Jim Y., Ya‐Chen Tina Shih, Marie A. Chisholm‐Burns, et al.. (2023). Racial and ethnic disparities in Medicare Part D medication therapy management services utilization. SHILAP Revista de lepidopterología. 9. 100222–100222. 2 indexed citations
5.
Wan, Jim Y., et al.. (2023). Solving racial/ethnic disparities associated with Medicare Part D Star Ratings. Current Medical Research and Opinion. 39(7). 963–971.
6.
Wan, Jim Y., Ya‐Chen Tina Shih, Marie A. Chisholm‐Burns, et al.. (2023). Racial and ethnic disparities in the enrolment of medicare medication therapy management programs. Journal of Pharmaceutical Health Services Research. 14(2). 188–197. 1 indexed citations
7.
8.
Shih, Ya‐Chen Tina, Jim Y. Wan, Marie A. Chisholm‐Burns, et al.. (2022). Cost-Effectiveness of Medication Therapy Management Program Across Racial and Ethnic Groups Among Medicare Beneficiaries. Value in Health. 26(5). 649–657. 4 indexed citations
9.
Wang, Junling, et al.. (2022). Comparison of catheter‐related bloodstream infection rates in pediatric patients receiving parenteral nutrition with soybean oil‐based intravenous fat emulsion versus a mixed oil fat emulsion. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 42(12). 898–904. 5 indexed citations
10.
Spivey, Christina A., Junling Wang, Ya‐Chen Tina Shih, et al.. (2019). Comparative Effectiveness of Medication Therapy Management Eligibility Criteria Across Racial/Ethnic Groups. Journal of the American Geriatrics Society. 67(3). 581–587. 6 indexed citations
11.
Hohmeier, Kenneth C., et al.. (2016). Co-creation of market expansion in point-of-care testing in the United States: Industry leadership perspectives on the community pharmacy segment. Research in Social and Administrative Pharmacy. 13(4). 746–753. 9 indexed citations
12.
Bell, Teresa M., et al.. (2015). Predictors of functional limitation trajectories after injury in a nationally representative U.S. older adult population. Annals of Epidemiology. 25(12). 894–900. 11 indexed citations
13.
Spivey, Christina A., Xianchen Liu, Jack Mardekian, et al.. (2015). Discontinuation/Interruption of Warfarin Therapy in Patients with Nonvalvular Atrial Fibrillation. Journal of Managed Care & Specialty Pharmacy. 21(7). 596–606. 24 indexed citations
14.
Wang, Junling, Xianchen Liu, & C. Daniel Mullins. (2011). Treatment adherence and persistence with duloxetine, venlafaxine XR, and escitalopram among patients with major depressive disorder and chronic pain-related diseases. Current Medical Research and Opinion. 27(7). 1303–1313. 18 indexed citations
15.
Wang, Junling, et al.. (2010). Pharmacists’ acceptable levels of compensation for MTM services: A conjoint analysis. Research in Social and Administrative Pharmacy. 7(4). 383–395. 15 indexed citations
16.
Wang, Junling, C. Daniel Mullins, Lawrence M. Brown, et al.. (2010). Disparity Implications of Medicare Eligibility Criteria for Medication Therapy Management Services. Health Services Research. 45(4). 1061–1082. 33 indexed citations
17.
Ma, Li, Yueping Liu, Xianghong Zhang, et al.. (2009). Effect of RhoA signaling transduction on expression of Ezrin in breast cancer cell lines.. PubMed. 28(2). 108–11. 8 indexed citations
18.
Wang, Junling, Nancy A. Miller, Meghan Hufstader, & Ying Bian. (2007). The Health Status of Asian Americans and Pacific Islanders and Their Access to Health Services. Social Work in Public Health. 23(1). 15–43. 5 indexed citations
19.
Zhao, Wenhua, et al.. (2002). [Study on the food consumption pattern of elderly people in four "cuisine" areas of China].. PubMed. 31(1). 34–7. 5 indexed citations
20.
Mullins, C. Daniel, et al.. (2002). Societal implications of the pharmacoeconomics of α1-antitrypsin deficiency. Expert Review of Pharmacoeconomics & Outcomes Research. 2(3). 243–249. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yelena Rozenfeld Breakdown of academic impact, for papers by Roland Rapold Breakdown of academic impact, for papers by Adrian R. Levy Breakdown of academic impact, for papers by Piotr Merks Breakdown of academic impact, for papers by Johanna Jyrkkä Breakdown of academic impact, for papers by Ellen S. Koster Breakdown of academic impact, for papers by Mary Teeling Breakdown of academic impact, for papers by Jeffrey J. Ellis Breakdown of academic impact, for papers by Antonio Gimeno‐Miguel Breakdown of academic impact, for papers by Sachin Kamal‐Bahl
Rankless by CCL
2026